Clinical guidelines for the management of type 1 diabetes in children in Saudi Arabia endorsed by the Saudi Society of Endocrinology and Metabolism, (SSEM)

Several guidelines have been set by the American Diabetes Association (ADA) and the International Society for Pediatric and Adolescent Diabetes (ISPAD); however, there are no specific guidelines for our region. The following are the clinical management guidelines that were developed and are endorsed by the Saudi Society of Endocrinology and Metabolism (SSEM) for assisting patients and providers in choosing appropriate health care plans. While these guidelines are useful aids that help providers to determine appropriate practices for children with diabetes, they are not meant to replace the clinical judgment of the individual provider or to establish a standard of care. This article covers several insulin therapy regimens in children with diabetes in Saudi Arabia, including the management of acute complications, sick day management and follow-ups.